Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Aquatic biota and human health are seriously threatened by the dramatic rise in antibiotics in environmental matrices. In this regard, the present study aims to improve knowledge of the combined effects of heterojunction design and defect engineering on the photocatalytic degradation of pharmaceuticals in aqueous matrices. Advantageously, the positioning of the valence band (VB) and conduction band (CB) levels of S@g-CN, being higher than those of BiMoO, demonstrates the feasibility of forming a type-II heterojunction between these materials. Initially, S and N defects were inserted in S-doped g-CN through an alkali-assisted calcination method (referred to as S@g-CN), as affirmed by the reduced concentrations of S and N in the end product. Thereafter, the BiMoO/S@g-CN photocatalysts (referred to as BSN) were synthesized a solvothermal method followed by calcination. Among the prepared samples, the integration of 10% S@g-CN with BiMoO (referred to as BSN (II)) demonstrated superior photocatalytic performance. Under optimal conditions, BSN (II) achieved a remarkable 92.4% degradation efficiency of tetracycline (TCL) in an aqueous solution after 60 min. The degradation rate of BSN (II) transcended that of pristine S@g-CN and BiMoO by 4.86 and 3.41 times, respectively. The higher number of active sites and the greater electron-hole pair separation are responsible for this improvement in the rate of TCL degradation. The photocatalyst also exhibited remarkable thermal/chemical stability and possessed reusability, as noted by 84% TCL degradation TCL up to 5 cycles. The radical scavenging experiment indicated O˙ as the primary contributor towards TCL degradation, with h and ˙OH playing a secondary role. Additionally, a seed germination experiment used to measure phytotoxicity determined that the treated effluent was non-phytotoxic, making it suitable for irrigation.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d4dt02334jDOI Listing

Publication Analysis

Top Keywords

tcl degradation
12
type-ii heterojunction
8
referred bsn
8
s@g-cn bimoo
8
degradation
7
tcl
5
fabrication 2d/2d
4
2d/2d bimoo/s@g-cn
4
bimoo/s@g-cn type-ii
4
heterojunction photocatalyst
4

Similar Publications

Background: Reliable hemoglobin (Hb) measurement is crucial for accurate estimation of anemia prevalence in population surveys. While portable meters like HemoCue devices are commonly used, studies show discrepancies in Hb readings. In fact, Hb assessment using automated hematology analyzers remains the most accurate method.

View Article and Find Full Text PDF

Designing a novel bio-platform as a nano-carrier with a significantly sustained drug release feature is a reliable and promising strategy for preventing the long-term dangers posed by bacterial infections. This route is favorable for various biomedical aspects, promoting the effectiveness of antibiotics in preventing bacterial growth sustainably. The purpose of this research is to synthesize a bio-based core-shell magnetic molecularly imprinted polymer (MIP) nano-carrier (FeO@MIP) through the Betti multi-component reaction (MCR) between dialdehyde pectin (DAP), β-naphthol, ethylenediamine (ETDA) (as cross-linking agent), and amine-functionalized FeO (as core).

View Article and Find Full Text PDF

The clinical application of specialized oral nutritional supplements (ONS) in managing hospitalized patients with diabetes mellitus necessitates rigorous evaluation of their effects on glycemic stability and nutritional parameters. This prospective study aimed to investigate the impact of a diabetes-specific ONS, Complete Nutrition Diabetic Formula, on glycemic control and key nutritional indices in diabetic inpatients. Forty adult inpatients diagnosed with diabetes mellitus requiring nutritional support were enrolled and completed the intervention.

View Article and Find Full Text PDF

EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma.

Cell Death Dis

July 2025

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, 100142, China.

T-cell lymphoma (TCL) is a rare subtype of non-Hodgkin lymphoma (NHL) that is associated with a poor prognosis. Although HDAC inhibitors have been approved for TCL treatment for several years, their expected therapeutic efficacy remains unmet in some patients. In this study, we discovered that TCL tumor cells develop resistance to HDAC inhibitor treatment by upregulating the methylation of lysine 27 on histone H3 (H3K27me3) levels.

View Article and Find Full Text PDF

Trospium chloride (TCL) is a quaternary amine derived from atropine, classified as an oral anticholinergic, the class of drugs most commonly used in the treatment of overactive bladder syndrome (OAB) and detrusor overactivity (DO). It is a large and hydrophilic molecule, with a low water-oil partition coefficient, which hinders the passage through lipid membranes and has demonstrated poor penetration into the central nervous system (CNS), generally without deleterious effects on the cognitive functions of healthy patients or those already with dementia. This molecule is excreted practically unchanged in the urine, and the metabolized part undergoes spontaneous hydrolysis.

View Article and Find Full Text PDF